Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/04/13/2421594/0/en/Highlight-Therapeutics-announces-follow-up-results-from-Phase-2b-study-of-BO-112-anti-PD1-in-confirmed-anti-PD1-progressor-melanoma-patients-at-AACR.html
https://www.globenewswire.com/news-release/2022/03/15/2403155/0/en/Highlight-Therapeutics-to-present-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2022.html
https://www.pharmiweb.com/press-release/2020-10-22/highlight-therapeutics-pivotal-advance-into-a-phase-iia-trial-to-examine-gastro-intestinal-cancer-therapy
https://pharmaphorum.com/news/highlight-therapeutics-trials-second-line-melanoma-combo-after-immunotherapy-fails/
https://www.globenewswire.com/news-release/2020/09/02/2087445/0/en/Highlight-Therapeutics-Announces-Second-Phase-II-Oncology-Collaboration-with-Merck.html